Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanophase Applies for Listing on NASDAQ Capital Market

Abstract:
Nanophase Technologies Corporation (Nasdaq:NANX), a technology leader in the development of advanced nanoengineered products, announced today that it has applied to transfer its listing from the NASDAQ Global Market to the NASDAQ Capital Market.

Nanophase Applies for Listing on NASDAQ Capital Market

Romeoville, Il | Posted on May 21st, 2011

Nanophase president and CEO Jess Jankowski commented, "We initially chose to be listed on the NASDAQ Global Market in 1997, but based on our current market capitalization and the listing criteria for the NASDAQ Global Market, we are now a better fit for the Nasdaq Capital Market trading system. We believe that applying for listing on the NASDAQ Capital Market serves the best interests of Nanophase and its shareholders."

Jankowski continued, "There are approximately 500 companies listed on the Nasdaq Capital Market, the largest of which has a market capitalization exceeding $2 billion. As a small-cap growth company, we believe the Capital Market will provide an appropriate platform for the listing of our securities. Companies listed on the NASDAQ Capital Market enjoy the benefits of a NASDAQ listing with peers generally closer to Nanophase in size. We are looking forward to continuing our longstanding relationship with NASDAQ."

On May 17, 2011, the Company received a notice from The NASDAQ Stock Market stating that the Company's most recently reported Shareholder's Equity of $9,979,845 was below the $10,000,000 required by NASDAQ Listing Rule 5450(b)(1)(A) (the "Rule"), and therefore, the Company was no longer in compliance with the continuing listing standards for the NASDAQ Global Market. The NASDAQ notice stated that the Company has been provided 45 calendar days to submit a plan to regain compliance or to apply for an alternate market listing. If such a plan were accepted, the Company would then have up to 180 days to evidence compliance. The NASDAQ notice has no immediate effect on the listing of the Company's common stock, which continues to trade under the symbol "NANX." The Company believes that a successful transfer to the NASDAQ Capital Market would continue to provide its shareholders the advantages of a NASDAQ listing.

####

About Nanophase Technologies Corporation
Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2008 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.

For more information, please click here

Contacts:
Nancy Baldwin
Investor Relations
630-771-6708

Copyright © GlobeNewswire, Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Materials/Metamaterials/Magnetoresistance

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024

Catalytic combo converts CO2 to solid carbon nanofibers: Tandem electrocatalytic-thermocatalytic conversion could help offset emissions of potent greenhouse gas by locking carbon away in a useful material January 12th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Patents/IP/Tech Transfer/Licensing

Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023

Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment: In mice, nanomedicine can remodel the immune microenvironment in lymph node and tumor tissue for long-term remission and lung tumor elimination in this form of metastasized breast cance May 13th, 2022

Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021

Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project